Tarsus Pharmaceuticals shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Tarsus Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Tarsus Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Tarsus Pharmaceuticals by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.4M | 23k | 59.43 |
| 2025-06-30 | $936k | 23k | 40.51 |
| 2025-03-31 | $1.1M | 22k | 51.37 |
| 2024-12-31 | $1.3M | 23k | 55.37 |
| 2024-09-30 | $707k | 22k | 32.89 |
| 2024-06-30 | $585k | 22k | 27.18 |
| 2023-12-31 | $315k | 16k | 20.25 |
| 2023-09-30 | $227k | 13k | 17.77 |
| 2023-06-30 | $231k | 13k | 18.07 |
| 2023-03-31 | $134k | 11k | 12.57 |
| 2022-12-31 | $157k | 11k | 14.66 |
| 2022-09-30 | $183k | 11k | 17.12 |
| 2022-06-30 | $156k | 11k | 14.62 |
| 2020-12-31 | $134k | 3.3k | 41.33 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors